These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1503408)

  • 1. Immunohistochemical analysis of the ras p21 oncoprotein in Hashimoto's thyroiditis.
    Kyriakoy D; Karkavitsas N; Eliopoulos G; Spandidos DA
    Anticancer Res; 1992; 12(4):1189-94. PubMed ID: 1503408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hashimoto's thyroiditis with papillary thyroid carcinoma (PTC)-like nuclear alterations express molecular markers of PTC.
    Prasad ML; Huang Y; Pellegata NS; de la Chapelle A; Kloos RT
    Histopathology; 2004 Jul; 45(1):39-46. PubMed ID: 15228442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase-2 expression in human thyroid carcinoma and Hashimoto's thyroiditis.
    Cornetta AJ; Russell JP; Cunnane M; Keane WM; Rothstein JL
    Laryngoscope; 2002 Feb; 112(2):238-42. PubMed ID: 11889377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of papillary carcinoma and Hashimoto's thyroiditis.
    Matesa-Anić D; Matesa N; Dabelić N; Kusić Z
    Acta Clin Croat; 2009 Mar; 48(1):9-12. PubMed ID: 19623865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo activated cytotoxic T cells in the thyroid infiltrate of patients with Hashimoto's thyroiditis.
    Del Prete GF; Vercelli D; Tiri A; Maggi E; Mariotti S; Pinchera A; Ricci M; Romagnani S
    Clin Exp Immunol; 1986 Jul; 65(1):140-7. PubMed ID: 3024884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of ras oncogene product P21 in thyroid tumors: an immunohistochemical study].
    Gui K
    Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):140-2, 12. PubMed ID: 2163739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexistent carcinoma of the thyroid gland and Hashimoto's thyroiditis.
    Strauss M; Laurian N; Antebi E
    Surg Gynecol Obstet; 1983 Sep; 157(3):228-32. PubMed ID: 6688483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of apoptosis in relation to tissue destruction associated with Hashimoto's autoimmune thyroiditis.
    Hammond LJ; Lowdell MW; Cerrano PG; Goode AW; Bottazzo GF; Mirakian R
    J Pathol; 1997 Jun; 182(2):138-44. PubMed ID: 9274522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine needle aspiration cytology of papillary carcinoma thyroid with Hashimoto's thyroiditis--report of two cases.
    Patil PV; Godhi AS; Sant AN
    Indian J Pathol Microbiol; 1997 Apr; 40(2):165-8. PubMed ID: 9257504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic and cytologic aspects of Hashimoto's thyroiditis during therapy with thymopentin].
    Aiello A; Cristofaro M; Carrozza F; Di Rienzo G; Carile L
    Clin Ter; 1990 May; 133(4):227-31. PubMed ID: 2142910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hashimoto's thyroiditis and carcinoma of the thyroid gland.
    Segal K; Ben-Bassat M; Avraham A; Har-El G; Sidi J
    Int Surg; 1985; 70(3):205-9. PubMed ID: 3841752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of calcitonin- and somatostatin-containing cells in thyroid lymphoma and in Hashimoto's thyroiditis.
    Baschieri L; Castagna M; Fierabracci A; Antonelli A; Del Guerra P; Squartini F
    Appl Pathol; 1989; 7(2):99-104. PubMed ID: 2567176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detecting the API2-MALT1 fusion gene and its significance in Hashimoto's thyroiditis and thyroid lymphomas].
    Yang WX; Li GD; Zhou Q; Liu WP; Li L; Chen N
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Jul; 36(4):484-7. PubMed ID: 16078567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of ras oncogene p21 antigen in normal and proliferative thyroid tissues.
    Johnson TL; Lloyd RV; Thor A
    Am J Pathol; 1987 Apr; 127(1):60-5. PubMed ID: 3105323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomorphologic aspects of thyroiditis. A study of 51 cases with functional, immunologic and ultrasonographic data.
    Jayaram G; Marwaha RK; Gupta RK; Sharma SK
    Acta Cytol; 1987; 31(6):687-93. PubMed ID: 3321814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
    Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
    J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant T-cell lymphoma of the thyroid gland associated with Hashimoto's thyroiditis.
    Motoi N; Ozawa Y
    Pathol Int; 2005 Jul; 55(7):425-30. PubMed ID: 15982218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexisting Hashimoto's thyroiditis with differentiated thyroid cancer and benign thyroid diseases: indications for thyroidectomy.
    Pisanu A; Piu S; Cois A; Uccheddu A
    Chir Ital; 2003; 55(3):365-72. PubMed ID: 12872571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Surgical treatment of Hashimoto's thyroiditis. Personal experience].
    Carli AF; Lottini M; Testa M; Neri A
    Minerva Chir; 2002 Apr; 57(2):117-22. PubMed ID: 11941286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation of number of intrathyroid lymphocytes with antimicrosomal antibody titer in Hashimoto's thyroiditis.
    Pandit AA; Vijay Warde M; Menon PS
    Diagn Cytopathol; 2003 Feb; 28(2):63-5. PubMed ID: 12561021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.